ArticleClinical and experimental medicine2024

Lymphoma relapse 1 year or later after immunochemotherapy in DLBCL patients: clinical features and outcome.

Hongyun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.